Benjamin Dach, Ph.D., Esq.


Benjamin Dach, Ph.D., Esq. is an accomplished patent attorney with extensive experience across multiple fields, including intellectual property litigation, counseling, and prosecution, spanning copyrights, trademarks, and patents.  

Prior to Weiss & Arons LLP, Benjamin worked at several prestigious law firms, including Quinn Emanuel LLP, WilmerHale LLP, Loeb & Loeb LLP, and Haug Partners LLP.  During his decade-plus of legal work experience, Benjamin has litigated several pharmaceutical patent cases involving drugs such as Lialda, Vyvanse, Intuniv, Oxtellar XR, Pomalyst, Revlimid, and Cabometyx.  Benjamin has also drafted and prosecuted dozens of patent applications, and counseled clients on IP relating to biological drugs, messenger ribonucleic acid (mRNA) vaccines, and clustered randomly interspaced palindromic repeats (CRISPR).  

Benjamin earned his Ph.D. in chemistry from Columbia University, where his research focused on solid-phase polymer synthesis on silicon wafers and silica nanoparticles, with applications in drug delivery, solar energy, and semiconductors. His thesis, titled "Designer Polymer Superstructures from Solid Phase 'Click' Chemistry," highlights his expertise in the field.  In addition to his scientific background, Benjamin also holds a J.D. from Fordham Law School, with a concentration in intellectual property and information law. 

Benjamin leverages his technical and legal backgrounds to maximize the value of his clients' IP portfolios.  His strong commitment to science and law has made him a highly sought-after attorney in the areas of intellectual property and patent law.

Rated by Super Lawyers